Gt biopharma to host virtual kol event showcasing its nk cell engager pipeline and broad indication potential on october 10, 2024

San francisco, california, sept. 24, 2024 (globe newswire) -- gt biopharma, inc. (the “company”) (nasdaq: gtbp), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the company's proprietary natural killer (nk) cell engager trike® platform, today announced it will host a virtual kol event on thursday, october 10, 2024 at 12:00 pm et. to register, click here.
GTBP Ratings Summary
GTBP Quant Ranking